Advair Diskus Powder
Product Images NDC 50090-4310

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Advair Diskus (NDC 50090-4310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Advair Diskus Spl Graphic 01)

FDA Label Image

Salmeterol Xinafoate Chemical Structure (Advair Diskus Spl Graphic 02)

FDA Label Image

Figure 1. Mean Percent Change From Baseline In Fev1 In Subjects With Asthma Previously Treated With Either Inhaled Corticosteroids Or Salmeterol (trial 1) (Advair Diskus Spl Graphic 03)

FDA Label Image

S:\project Files\a\advair Diskus Nda 021077\figures\advair-diskus-spl-graphic-04.jpg (Advair Diskus Spl Graphic 04)

FDA Label Image

Figure 3. Percent Change In Serial 12-hour Fev1 In Subjects With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (trial 1) (Advair Diskus Spl Graphic 05)

This text appears to contain information about a medication named "ADVAIR DISKUS 100D" and its dosage instructions. It mentions the change in FEV1 (Forced Expiratory Volume in 1 second), relative to day 1 in Basel. The dosage instructions include taking one dose daily of Salmeterol 80 mcg, Fluticasone Propionate 100 mcg, and two doses of Tiotropium 1.25 mcg. The text also references "Fitasone proporat" and "Weekiz."*

FDA Label Image

Figure 4. Predose Fev1: Mean Percent Change From Baseline In Subjects With Chronic Obstructive Pulmonary Disease (Advair Diskus Spl Graphic 06)

FDA Label Image

Figure 5. Two-hour Postdose Fev1: Mean Percent Changes From Baseline Over Time In Subjects With Chronic Obstructive Pulmonary Disease (Advair Diskus Spl Graphic 07)

FDA Label Image

Figure A (Advair Diskus Spl Graphic 08)

This is a list of parts of a smoking pipe: Outer Case, Mouthpiece, and Thumb Grip. Each part plays a specific role in the functionality and design of the smoking pipe. The Outer Case serves as a protective covering for the pipe. The Mouthpiece is the part that is placed in the mouth for smoking. The Thumb Grip assists in holding and handling the pipe comfortably.*

FDA Label Image

Figure B (Advair Diskus Spl Graphic 09)

FDA Label Image

Figure C (Advair Diskus Spl Graphic 10)

FDA Label Image

Figure D (Advair Diskus Spl Graphic 11)

FDA Label Image

Figure E (Advair Diskus Spl Graphic 12)

FDA Label Image

Figure F (Advair Diskus Spl Graphic 13)

FDA Label Image

Figure G (Advair Diskus Spl Graphic 14)

FDA Label Image

Figure H (Advair Diskus Spl Graphic 15)

FDA Label Image

Label Image (Lbl500904310)

This is a description of Advair Diskus inhalation powder medication. Each blister contains 100 mcg of fluticasone propionate and 72.5 mcg of salmeterol xinafoate, equivalent to 50 mg of salmeterol base. It should be stored at 68-77 degrees Fahrenheit in a dry place away from direct heat or sunlight. The product comes in a Diskus inhalation device with a foil strip containing 60 blisters. For dosage information, refer to the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.